Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonradioactive chromium technique for red cell labeling.

H A Sioufi1, L N Button, M S Jacobson

  • 1Department of Medicine, Children's Hospital, Boston, Mass.

Vox Sanguinis
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ineffectiveness of prophylactic epsilon aminocaproic acid in severe hemophilia.

The New England journal of medicine·2011
Same author

Effects of platelet rich plasma and acellular bone marrow on gene expression patterns and DNA content of equine suspensory ligament explant cultures.

Equine veterinary journal·2008
Same author

Pediatric obesity prevention and management.

Minerva pediatrica·2004
Same author

Evaluation of an automated system for the collection of packed RBCs, platelets, and plasma.

Transfusion·2000
Same author

American Academy of Pediatrics. Committee on Nutrition. Calcium requirements of infants, children, and adolescents.

Pediatrics·1999
Same author

Long-term results in pediatric ABO-incompatible liver transplantation.

Transplantation proceedings·1999

Nonradioactive chromium (52Cr) effectively labels red blood cells for survival studies, showing comparable results to radioactive chromium (51Cr). This method offers a safe alternative when radioactivity is not advisable.

Area of Science:

  • Hematology
  • Nuclear Medicine
  • Analytical Chemistry

Background:

  • Red blood cell survival studies are crucial for diagnosing and managing various anemias and hematological disorders.
  • Chromium-51 (51Cr) has been the standard radioisotope for labeling red blood cells, but its use involves radioactivity.
  • Alternative labeling methods are needed for situations where radioactivity is contraindicated.

Purpose of the Study:

  • To evaluate the efficacy of nonradioactive chromium (52Cr) for labeling red blood cells.
  • To compare the red blood cell survival rates using 52Cr with those using 51Cr.
  • To determine the utility of 52Cr labeling in clinical settings where radioactivity is a concern.

Main Methods:

  • Red blood cells from rhesus monkeys and human subjects were labeled with nonradioactive chromium (52Cr).

Related Experiment Videos

  • Red blood cell survival was assessed using atomic absorption spectrophotometry.
  • Survival data for 52Cr-labeled cells were compared to historical data for 51Cr-labeled cells.

    • Main Results:

    • Atomic absorption spectrophotometry successfully detected 52Cr-labeled red blood cells in circulation.
    • Red blood cell survival rates using 52Cr were found to be insignificantly different from those labeled with 51Cr.
    • The 52Cr labeling method demonstrated comparable red cell survival to the 51Cr method.

    Conclusions:

    • Nonradioactive chromium (52Cr) is a viable alternative for red blood cell labeling in survival studies.
    • 52Cr labeling offers a safe option when radioactive isotopes like 51Cr cannot be used.
    • This technique allows for sequential labeling or use when radioactivity is contraindicated, expanding diagnostic capabilities.